UM

Browse/Search Results:  1-10 of 24 Help

Selected(0)Clear Items/Page:    Sort:
Tetramethylpyrazine nitrone exerts neuroprotection via activation of PGC-1α/Nrf2 pathway in Parkinson's disease models Journal article
Guo, Baojian, Zheng, Chengyou, Cao, Jie, Luo, Fangcheng, Li, Haitao, Hu, Shengquan, Mingyuan Lee, Simon, Yang, Xifei, Zhang, Gaoxiao, Zhang, Zaijun, Sun, Yewei, Wang, Yuqiang. Tetramethylpyrazine nitrone exerts neuroprotection via activation of PGC-1α/Nrf2 pathway in Parkinson's disease models[J]. Journal of Advanced Research, 2024, 64, 195-211.
Authors:  Guo, Baojian;  Zheng, Chengyou;  Cao, Jie;  Luo, Fangcheng;  Li, Haitao; et al.
Favorite | TC[WOS]:4 TC[Scopus]:4  IF:11.4/11.0 | Submit date:2024/02/22
Nuclear Factor Erythroid-2-related Factor 2  Parkinson's Disease  Peroxisome Proliferator-activated Receptor γ Co-activator 1α  Tetramethylpyrazine Nitrone  
Tetramethylpyrazine Nitrone Promotes the Clearance of Alpha-Synuclein via Nrf2-Mediated Ubiquitin–Proteasome System Activation Journal article
Guo, Baojian, Zheng, Chengyou, Cao, Jie, Qiu, Xiaoling, Luo, Fangcheng, Li, Haitao, Lee, Simon Mingyuan, Yang, Xifei, Zhang, Gaoxiao, Sun, Yewei, Zhang, Zaijun, Wang, Yuqiang. Tetramethylpyrazine Nitrone Promotes the Clearance of Alpha-Synuclein via Nrf2-Mediated Ubiquitin–Proteasome System Activation[J]. NeuroMolecular Medicine, 2024, 26(1), 9.
Authors:  Guo, Baojian;  Zheng, Chengyou;  Cao, Jie;  Qiu, Xiaoling;  Luo, Fangcheng; et al.
Favorite | TC[WOS]:1 TC[Scopus]:1  IF:3.3/3.6 | Submit date:2024/05/16
Nuclear Factor Erythroid-2-related Factor 2  Parkinson’s Disease  Peroxisome Proliferator-activated Receptor γ Co-activator 1α  Tetramethylpyrazine Nitrone  Ubiquitin–proteasome System  Α-synuclein  
J24335 exerts neuroprotective effects against 6-hydroxydopamine-induced lesions in PC12 cells and mice Journal article
Pan, Zhijian, Shao, Min, Zhao, Chen, Yang, Xuanjun, Li, Haitao, Cui, Guozhen, Liang, Xiaonan, Yu, Chao Wu, Ye, Qingqing, Gao, Cheng, Di, Lijun, Chern, Ji Wang, Zhou, Hefeng, Lee, Simon Ming Yuen. J24335 exerts neuroprotective effects against 6-hydroxydopamine-induced lesions in PC12 cells and mice[J]. European Journal of Pharmaceutical Sciences, 2024, 194, 106696.
Authors:  Pan, Zhijian;  Shao, Min;  Zhao, Chen;  Yang, Xuanjun;  Li, Haitao; et al.
Favorite | TC[WOS]:0 TC[Scopus]:0  IF:4.3/4.2 | Submit date:2024/04/02
6-ohda  J24335  Mitochondria Dysfunction  Neurotoxicity  Parkinson's Disease  Target Prediction  
Power Flow Control-Based Regenerative Braking Energy Utilization in AC Electrified Railways: Review and Future Trends Journal article
Chen, Junyu, Hu, Haitao, Wang, Minghao, Ge, Yinbo, Wang, Ke, Huang, Yi, Yang, Kai, He, Zhengyou, Xu, Zhao, Li, Yunwei Ryan. Power Flow Control-Based Regenerative Braking Energy Utilization in AC Electrified Railways: Review and Future Trends[J]. IEEE Transactions on Intelligent Transportation Systems, 2024, 25(7), 6345 - 6365.
Authors:  Chen, Junyu;  Hu, Haitao;  Wang, Minghao;  Ge, Yinbo;  Wang, Ke; et al.
Favorite | TC[WOS]:23 TC[Scopus]:26  IF:7.9/8.3 | Submit date:2024/05/16
Electrified Railways  Energy Efficiency  Energy Efficiency  Load Flow  Load Flow Control  Market Research  Power Flow Control  Rail Transportation  Regenerative Braking Energy  Topology  Transformers  
Antagonizing pathological α-synuclein-mediated neurodegeneration by J24335 via the activation of immunoproteasome Journal article
Pan, Zhijian, Yu, Chao Wu, Zhao, Chen, Shao, Min, Yang, Xuanjun, Liang, Xiaonan, Li, Haitao, Lu, Yucong, Ye, Qingqing, Chern, Ji Wang, Lu, Jiahong, Zhou, Hefeng, Lee, Simon Ming Yuen. Antagonizing pathological α-synuclein-mediated neurodegeneration by J24335 via the activation of immunoproteasome[J]. Toxicology and Applied Pharmacology, 2023, 480, 116745.
Authors:  Pan, Zhijian;  Yu, Chao Wu;  Zhao, Chen;  Shao, Min;  Yang, Xuanjun; et al.
Favorite | TC[WOS]:1 TC[Scopus]:1  IF:3.3/3.6 | Submit date:2024/01/02
Immunoproteasome  J24335  Lmp7  Parkinson's Disease  Protein Degradation  Α-synuclein  
Editorial: Community series in epigenetics of the immune component of inflammation-volume II Journal article
Yan-Jun Liu, Hai-Jing Zhong, Haitao Wang, Cheong-Meng Chong, Guan-Jun Yang. Editorial: Community series in epigenetics of the immune component of inflammation-volume II[J]. Frontiers in Immunology, 2023, 14, 1266133.
Authors:  Yan-Jun Liu;  Hai-Jing Zhong;  Haitao Wang;  Cheong-Meng Chong;  Guan-Jun Yang
Favorite | TC[WOS]:2 TC[Scopus]:2  IF:5.7/6.8 | Submit date:2023/12/11
Epigenetics  Genome Modification  Immune Response  Inflammation  Post-translational Modifications  Posttranscriptional Modifications  
Editorial: Epigenetics of the immune component of inflammation Journal article
Liu, Yan Jun, Wang, Haitao, Zhong, Hai Jing, Chong, Cheong Meng, Yang, Guan Jun. Editorial: Epigenetics of the immune component of inflammation[J]. Frontiers in Immunology, 2022, 13.
Authors:  Liu, Yan Jun;  Wang, Haitao;  Zhong, Hai Jing;  Chong, Cheong Meng;  Yang, Guan Jun
Favorite | TC[WOS]:7 TC[Scopus]:8  IF:5.7/6.8 | Submit date:2023/03/06
Dna Modification  Epigenetic Regulation  Immune Component  Inflammation  Non-coding Rna Regulation  Post-translational Modifications  
Epigenetics of the Immune Component of Inflammation Journal article
Liu, Yan-Jun, Wang, Haitao, Zhong, Hai-Jing, Chong, Cheong-Meng, Yang, Guan-Jun. Epigenetics of the Immune Component of Inflammation[J]. Frontiers in Immunology, 2022.
Authors:  Liu, Yan-Jun;  Wang, Haitao;  Zhong, Hai-Jing;  Chong, Cheong-Meng;  Yang, Guan-Jun
Favorite | TC[WOS]:7 TC[Scopus]:8  IF:5.7/6.8 | Submit date:2022/08/12
DeepDRiD: Diabetic Retinopathy—Grading and Image Quality Estimation Challenge Journal article
Liu, Ruhan, Wang, Xiangning, Wu, Qiang, Dai, Ling, Fang, Xi, Yan, Tao, Son, Jaemin, Tang, Shiqi, Li, Jiang, Gao, Zijian, Galdran, Adrian, Poorneshwaran, J. M., Liu, Hao, Wang, Jie, Chen, Yerui, Porwal, Prasanna, Wei Tan, Gavin Siew, Yang, Xiaokang, Dai, Chao, Song, Haitao, Chen, Mingang, Li, Huating, Jia, Weiping, Shen, Dinggang, Sheng, Bin, Zhang, Ping. DeepDRiD: Diabetic Retinopathy—Grading and Image Quality Estimation Challenge[J]. Patterns, 2022, 3(6).
Authors:  Liu, Ruhan;  Wang, Xiangning;  Wu, Qiang;  Dai, Ling;  Fang, Xi; et al.
Favorite | TC[WOS]:44 TC[Scopus]:84  IF:6.7/6.6 | Submit date:2022/08/02
Transforming primary human hepatocytes into hepatocellular carcinoma with genetically defined factors Journal article
Jiang, Zhiwu, Cheng, Lin, Wu, Zhiping, Zhou, Linfu, Wang, Haitao, Hong, Qilan, Wu, Qiting, Long, Youguo, Huang, Yunlin, Xu, Gaoqi, Yao, Yao, Tang, Zhaoyang, Zhang, Zhenfeng, Yang, Lili, Luo, Wei, Yang, Jie, Gong, Likun, Liu, Pentao, Chen, Xinwen, Cui, Shuzhong, Zhang, Qi, Li, Yinxiong, Li, Peng. Transforming primary human hepatocytes into hepatocellular carcinoma with genetically defined factors[J]. EMBO Reports, 2022, 23(6), e54275.
Authors:  Jiang, Zhiwu;  Cheng, Lin;  Wu, Zhiping;  Zhou, Linfu;  Wang, Haitao; et al.
Favorite | TC[WOS]:9 TC[Scopus]:9  IF:6.5/8.3 | Submit date:2022/05/17
Biomarkers  Hepatocellular Carcinoma  Humanized Mouse Models  Immunotherapy  Oncogenes